A biotech market intelligence workstation with FDA calendar and stock alert screens

NASDAQ + NYSE biotech catalyst alerts

Track FDA Approvals Before They Trigger Biotech Breakouts

FDA Stocks tracks publicly traded biotech companies approaching pivotal FDA approval decisions, then sends concise email and SMS updates before the catalyst window arrives.

PDUFA decision dates

NDA/BLA approval filings

NYSE/Nasdaq listed companies

Catalyst machine

A focused filter for biotech approval events.

The universe of biotech stocks is noisy. FDA Stocks narrows attention to companies with consequential regulatory moments approaching, then packages the event into a fast read.

Approval Calendar

Upcoming FDA action dates, advisory committee markers, and approval window changes.

Market Context

Ticker, exchange, market cap band, recent price action, and event proximity in one view.

Email + SMS

Digest-style email updates and text nudges when a catalyst moves into the near window.

Built for watchlists

Designed for traders who want the catalyst, not the clutter.

Each alert is structured to make the next research step obvious: company, ticker, drug, indication, event type, estimated timing, and why the date matters.

FDA Catalyst Brief

Company Arvinas

Ticker $ARVN

PDUFA Date June 5, 2026

Drug Vepdegestrant

Indication ESR1-mutated breast cancer

Why it matters

First major PROTAC oncology approval shot, backed by Pfizer. Institutional-heavy setup may move pre-decision rather than trade like a lottery catalyst.

Base approval probability ~85%

Early access

Be first in line for the FDA Stocks alert list.

Join the list

FDA Stocks is informational only and is not investment advice or a recommendation to buy or sell securities.